Article

Challenges in systematic reviews of complementary and alternative medicine topics.

Southern California Evidence-based Practice Center, RAND Corporation, Santa Monica, California 90401, USA.
Annals of internal medicine (Impact Factor: 16.1). 07/2005; 142(12 Pt 2):1042-7.
Source: PubMed

ABSTRACT The use of complementary and alternative medicine (CAM) continues to grow in the United States. The Agency for Healthcare Research and Quality has devoted a substantial proportion of the Evidence-based Practice Center (EPC) program to systematic reviews of CAM. Such syntheses present different challenges from those conducted on western medicine topics, and in many ways are more difficult. We discuss 3 challenges: identifying evidence about CAM, assessing the quality of individual studies, and addressing rare serious adverse events. We use illustrations from EPC evidence reports to show readers approaches to the 3 areas and then present specific recommendations for each issue.

0 Bookmarks
 · 
112 Views
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Mandoora chooranam(MC) has been used for treatment of Iron deficiency anaemia (IDA)which is a herbo-mineral formulation. As a mandate,steps were taken to evaluate safety profile of MC in rats following OECD guidelines. Acute toxicity studies were done on female wistar albino rat under OECD guidelines 423 and 28 days repeated oral toxicity studies were done on both sexof wistar albino rats under OECD guidelines 407.Acute toxicity studies, MCwas administered single oral dose and observed for 14 days. In Acute toxicity studies no toxic effects were observed upto the dose level of 2000mg/kg body weight.Sub-acute toxicity studies were carried in four different groups in which MC was administrated orally to rats once daily for 28 days in various dosesranging from 40, 200,400 mg/kg for rat respectively. Detailed hematological, biochemical, necropsy and histopathological evaluation of organs was performed for all animals. No toxic effect was observed upto 400mg/kg in sub-acute toxicity studies of Mandoora chooranam.. INTRODUCTION The interventional drug Mandoora chooranam (MC) has been quoted by Sarabendira vaidya muraigal Paandu Kamalai Roga Sikitchai for the treatment of Paandu (IDA) [1] .Iron Deficiency Anaemia (IDA) is one of the most widespread diseases all over the world, incidence is high in reproductive age of women and children [2] .Among worldwide distribution of anaemia approximately half of them are due to Iron deficiency anaemia. Women are affected more than men and it's widely prevalence is about700-800 million people in under developed countries and 60 – 70 million in developed countries [3] It is the most important cause of microcytic hypochromic anaemia in which all the three red cell indices (MCV, MCH and MCHC) are reduced and occurs due to defective haemoglobin synthesis . [4] . Major causes of iron deficiency are chronic blood loss, increased iron requirement, iron malabsorption and inadequate dietary intake [5] There are many alternative treatments available that can treat the IDA. Herbs and minerals have been in use since long time to treat various diseases . [6] . However, many issues related to a lack of scientific evidence about the efficacy and safeties of the drugs remain unresolved [7,8] . The Pre-clinical toxicity studies were essential for determining a safe dose for human trials 9 MATERIALS & METHODS .Consequently an effort was made to evaluate acute and sub-acute toxicity of herbo-mineral siddha formulation of Mandoora chooranam in laboratory animals. Preparation of the Mandoora chooranam: a)Ingredients: Purified Mandooram(Ferroso ferric oxide), Kodiveli Root(Plumbago zeylanica), Thippili(Piper longum), Kadukkai Thol(Terminalia chebula), Nellimulli(Emblica officinalis), Chevuiyam(Pipernigrum), Maramanjal(Coccinium fenestratum), Chukku(Zingiber officinale), Milagu(Pipernigrum), Thandrikkai(Terminalia bellarica), Kandthippili (Piper longum),
  • [Show abstract] [Hide abstract]
    ABSTRACT: Infertility is one of the most extremely tragic all over the world. Despite recent advances in the treatment of male infertility, the problem has not been satisfactorily tackled. The male infertility is mainly due to an inadequate number of spermatozoa in the semen, the failure of the spermatozoa to move with sufficient vigour towards their goal. Herbal medicines have been broadly used in developed countries hence they are natural and comparatively safe. They contain plant materials as their pharmacologically active components. Aim of the study is to evaluate the acute and sub-acute toxicity of the spermatogenic siddha drug Magizhampattai Chooranam (MPC). For acute studies, different doses of MPC were administered orally to rats once daily for one week. For sub-acute studies, different doses of IC were administered orally to rats once daily for 28 days in various doses at 250, 500, 1000 mg/kg of body weight. Detailed hematological, biochemical, necropsy and Histopathological evaluation of organs was performed for all animals. Histopathological analysis revealed that Spleen, of treated groups did not show any signs of toxicity. No impairment in hepatic, renal, haemopoietic functions were observed throughout the study. INTRODUCTION: Infertility is the failure of a couple to conceive a pregnancy after trying to do so for at least one full year. Approximately 20% of couples struggle with infertility at any given time. Infertility has increased as a problem over the last 30 years 1 . Male reproductive health has social and psychological impact on normal life 2 . Male infertility is commonly due to deficiencies in the semen and semen quality is used as a surrogate measure of male fecundity 3 . Male reproductive medicine and surgery remains one of the most actively evolving areas in urology, with a variety of therapeutic modalities under investigation 4 .

Full-text (2 Sources)

Download
78 Downloads
Available from
Jun 2, 2014